文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Variations in Volume: Breast Size in Trans Women in Relation to Timing of Testosterone Suppression.

作者信息

Boogers Lidewij S, Sardo Infirri Sebastiaan A, Bouchareb Asma, Dijkman Benthe A M, Helder Danithsia, de Blok Christel J M, Liberton Niels P T J, den Heijer Martin, van Trotsenburg A S Paul, Dreijerink Koen M A, Wiepjes Chantal M, Hannema Sabine E

机构信息

Center of Expertise on Gender Dysphoria, Amsterdam UMC location VUmc, 1081 HZ Amsterdam, the Netherlands.

Amsterdam Gastroenterology Endocrinology Metabolism, 1081 HZ Amsterdam, the Netherlands.

出版信息

J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1404-e1410. doi: 10.1210/clinem/dgae573.


DOI:10.1210/clinem/dgae573
PMID:39150977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12012776/
Abstract

CONTEXT: Breast development is an important outcome for trans women receiving gender-affirming hormone therapy (GAHT). Limited breast development has been reported, possibly because of testosterone exposure during puberty. The impact of puberty suppression (PS) on breast development is unclear. OBJECTIVE: To investigate the impact of PS and timing of PS prior to GAHT on breast volume and satisfaction. METHODS: In a cross-sectional study at a tertiary gender identity clinic, 60 trans women (aged 17-57 years) after 4.5 ± 1.7 years of GAHT were included, of whom 23 initiated PS early in puberty (Tanner stage G2-3), 17 late in puberty (Tanner stage G4-5), and 20 started GAHT in adulthood without prior PS. Breast volume was measured with a 3D scanner and breast satisfaction measured with a questionnaire. Comparisons of breast volumes were adjusted for fat percentage. RESULTS: Median breast volume was 115 mL (IQR, 68; 203), ie, bra cup size < A. Breast volume was 47 mL (95% CI, -9; 104) larger in the late PS group compared to early PS but this difference was only 4 mL (95% CI, -67; 75) after correction for fat percentage. Breast volume in the adult group was comparable to the early and late PS groups (adult vs early PS 27 mL [95% CI, -28; 83] and adult vs late PS -20 mL [95% CI, -80; 40]). In total, 68% of subjects were satisfied with breast size (57% of early PS, 76% of late PS, and 70% of adult group). CONCLUSION: Early start of PS was not associated with larger breast volume, suggesting that pubertal testosterone exposure does not affect breast volume after subsequent GAHT. Despite limited breast size, most trans women were satisfied with their breast development.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0f/12012776/a0ba9c30c5ac/dgae573f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0f/12012776/36b7e2100433/dgae573f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0f/12012776/343dcbeadcff/dgae573f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0f/12012776/a0ba9c30c5ac/dgae573f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0f/12012776/36b7e2100433/dgae573f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0f/12012776/343dcbeadcff/dgae573f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0f/12012776/a0ba9c30c5ac/dgae573f3.jpg

相似文献

[1]
Variations in Volume: Breast Size in Trans Women in Relation to Timing of Testosterone Suppression.

J Clin Endocrinol Metab. 2025-4-22

[2]
Shaping the Skeleton: Impact of GnRH Analogue and Sex Hormone Therapy on Skeletal Dimensions in Transgender Individuals.

J Clin Endocrinol Metab. 2025-4-22

[3]
Time Course of Body Composition Changes in Transgender Adolescents During Puberty Suppression and Sex Hormone Treatment.

J Clin Endocrinol Metab. 2024-7-12

[4]
Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment.

J Clin Endocrinol Metab. 2021-1-23

[5]
Changes in affect variability after starting gender-affirming hormone therapy.

Psychoneuroendocrinology. 2025-5

[6]
Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy.

Front Endocrinol (Lausanne). 2024

[7]
Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.

J Bone Miner Res. 2021-5

[8]
Just as Tall on Testosterone; a Neutral to Positive Effect on Adult Height of GnRHa and Testosterone in Trans Boys.

J Clin Endocrinol Metab. 2023-1-17

[9]
Timing of Puberty Suppression and Surgical Options for Transgender Youth.

Pediatrics. 2020-11

[10]
Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.

J Sex Med. 2022-5

本文引用的文献

[1]
A comparative study of 3D measuring methods for monitoring breast volume changes.

PLoS One. 2024

[2]
Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.

BMC Pharmacol Toxicol. 2023-12-20

[3]
Normalization of puberty and adult height in girls with Turner syndrome: results of the Swedish Growth Hormone trials initiating transition into adulthood.

Front Endocrinol (Lausanne). 2023

[4]
Effectiveness of Puberty Suppression with Gonadotropin-Releasing Hormone Agonists in Transgender Youth.

Transgend Health. 2021-2-15

[5]
What is the most anticipated change induced by treatment using gender-affirming hormones in individuals with gender incongruence?

Int J Urol. 2021-5

[6]
The Health and Well-Being of Transgender Australians: A National Community Survey.

LGBT Health. 2021-1

[7]
Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment.

J Clin Endocrinol Metab. 2021-1-23

[8]
State of Mental Health Among Transgender Individuals in Pakistan: Psychological Resilience and Self-esteem.

Community Ment Health J. 2020-5

[9]
Frequency, Determinants, and Satisfaction of Breast Augmentation in Trans Women Receiving Hormone Treatment.

J Sex Med. 2019-12-2

[10]
Breast development and satisfaction in women with disorders/differences of sex development.

Hum Reprod. 2019-12-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索